Follow Up Length: 24 month(s)

3 trials

Sponsors

Queen Mary University of London (UK), Velindre NHS Trust (UK), Lancashire Teaching Hospitals NHS Trust (UK)

Conditions

Topic: CancerTopic: National Cancer Research Network

Phase 1

A phase I/II trial of isotoxic accelerated radiotherapy in the treatment of patients with non-small cell lung cancer

Active, not recruitingISRCTN74841904

Velindre NHS Trust (UK)Topic: National Cancer Research Network

Start: 2012-03-12Target: 121Updated: 2019-10-07

Phase 2

A Phase II, Open Label, Multicenter Randomised Controlled Trial Comparing Hyperthermia Plus Mitomycin To Mitomycin Alone, In Patients with Intermediate Risk Non-Muscle Invasive Bladder Cancer

Active, not recruitingISRCTN23639415

Queen Mary University of London (UK)Topic: Cancer

Start: 2014-03-19Target: 191Updated: 2024-03-18

Phase 3

Comparing hospital and telephone follow up for women treated for endometrial cancer (ENDCAT): ENDometrial CAncer Telephone follow up trial)

Active, not recruitingISRCTN75220876

Lancashire Teaching Hospitals NHS Trust (UK)Topic: National Cancer Research Network

Start: 2012-03-23Target: 256Updated: 2022-11-07

Related Papers

Initial results of the phase ib/II, I-START trial: Isotoxic accelerated radiotherapy for the treatment of stage II-IIIb NSCLC.

Journal of Clinical Oncology2018-05-205 citations